Brought to you by:
-
Select gene SNPs found to be associated with venous ulcer formation and persistence
Looking to the future, genetic testing may play a role in guiding the intensity of therapeutic interventions and preventive strategies in patients with venous disease. This finding comes from a case-control study on the clinical implications of genetic variation of venous stasis ulceration, presented by lead researcher, Rabih Chaer, MD, at the 2022 annual meeting…
-
Increased market competition linked to higher odds of revascularization among asymptomatic patients with moderate carotid stenosis
A vascular surgery research team with a growing reputation for its work investigating appropriateness in care in the peripheral vascular bed recently uncovered an association between increased regional market competition among proceduralists and higher odds of revascularization being carried out for moderate- versus high-grade asymptomatic carotid stenosis. The investigators detected no similar impact among symptomatic…
-
Diabetes: Impact of local medicolegal landscapes on costs
More litigious U.S. states did not see decreased amputation rates over those where the medicolegal environment was less adverse, according to an analysis of Medicare data exploring the association between the realities of local medical-legal landscapes and diabetes-related care costs. A team of researchers from the Mayo Clinic Arizona in Phoenix and UMass Memorial Health…
-
SCVS 2022: ‘We should not allow our industry relationships influence how we choose to treat patients’
Industry players and device makers have helped spark new science and innovation in vascular surgery amid flatlining National Institutes of Health (NIH) funding, but physicians must pay heed to the conflicting agendas in the partnerships formed with these companies, a focus session on ethical issues in practice at the 2022 annual symposium of the Society…
-
bioresorbable scaffolds, Drug-eluting technology, EFEMORAL I, Efemoral Medical, Midwestern Vascular Surgical Society, MVSS, PAD, sirolimus
Potential ‘new paradigm’ in treatment of long occlusive lesions emerges
Vascular surgeon Lewis Schwartz, MD, has had an interest in biomedical engineering since very early in his career. So his involvement in the early-stage Efemoral vascular scaffold system marks a significant milestone in a mission to save legs and provide better care for patients with peripheral arterial disease (PAD). Schwartz, a clinical professor of surgery…
-
SVS creates membership section for women
Women make up a growing percentage of vascular surgeons. And they now have a new professional membership home within the Society for Vascular Surgery (SVS)—the SVS Women’s Section. SVS leadership approved the new membership section in 2021. It is intended as a partnership with the growing women’s vascular surgery membership of SVS and the larger…
-
Boston calling: Registration for VAM 2022 is open
Registration and housing for the Society for Vascular Surgery (SVS) 2022 Vascular Annual Meeting (VAM) are now open. This year’s premiere educational event for all vascular professionals is set for June 15–18 at the Hynes Convention Center in Boston. The headquarters hotel is the Sheraton Boston Hotel, which is directly accessible to the Hynes Convention…
-
Database analysis findings ‘matched precisely’ with reported reasons for venous stent recalls
A recent analysis recalled Venovo and Vici venous stents—initiated last year—characterized “significant differences” between reported device and patient issues, and subsequent interventions for the two systems, with findings ultimately matching the reasons given for the recall at the time. A team of researchers from the Virginia Commonwealth University School of Medicine in Richmond, Virginia, tapped…
-
Life of Achilles: Turning weakness into bursts of innovation, creativity
Themes rooted in the life of Achilles, the heroic figure from Greek mythology, and the concept of “emotional stamina” underpinned the message delivered from the presidential podium during the 2022 winter annual meeting of the Vascular and Endovascular Surgery Society (VESS). The specter of Achilles has loomed large over the life and times of the…
-
The top 10 most popular Vascular Specialist stories in February
February’s top 10 includes a highlight from the 2022 Vascular and Endovascular Surgery Society (VESS) winter annual meeting and an interview with Melissa Kirkwood, MD, and colleagues at UT Southwestern in Dallas, Texas, regarding the lightweight shield designed to reduce radiation dose during complex endovascular procedures. Additionally, this month’s highlights include the important discussion of…